US Patent 9631026 Antibodies that specifically bind to TIM3
Patent 9631026 was granted and assigned to Cellerant Therapeutics on April, 2017 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 9631026 Antibodies that specifically bind to TIM3
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.